{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:27:25Z","timestamp":1754159245475,"version":"3.41.2"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) is autosomal recessive hereditary disease caused by tartrate resistant acid phosphatase 5 (ACP5) mutations. The symptoms mainly involve the bone, immune system and nervous system, and the typical manifestations are short stature, abnormal development of long diaphyseal epiphysis, flat vertebra, and prone to various autoimmune diseases. Some children have muscle spasm, mild mental retardation, intracranial calcification and other neurological manifestations. Here we reported two cases of SPENCDI caused by a new mutation in ACP5. The clinical manifestations were autoimmune hemolytic anemia, immune thrombocytopenia, abnormal bone development, intracranial calcification, short stature, and growth retardation. The patients were girls and diagnosed with SPENCDI by genetic test.<\/jats:p>","DOI":"10.3389\/fphar.2025.1588003","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:26:01Z","timestamp":1753421161000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Successful treatment of spondyloenchondrodysplasia with immune dysregulation using tofacitinib and ruxolitinib: a report of two pediatric cases"],"prefix":"10.3389","volume":"16","author":[{"given":"Chengzhu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linhai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songji","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaju","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S409","DOI":"10.1007\/s00586-012-2518-2","article-title":"Dysmorphic facies and diffuse posterior spine ankylosis in a patient with unusual form of spondyloenchondrodysplasia (spranger type IV)","volume":"22","author":"Al Kaissi","year":"2013","journal-title":"Eur. Spine J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e60314","DOI":"10.7759\/cureus.60314","article-title":"Spondyloenchondrodysplasia with immune dysregulation, but without skeletal dysplasia, in a six-year-old boy: a case report","volume":"16","author":"Al-Kateb","year":"2024","journal-title":"Cureus"},{"key":"B3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/art.39810","article-title":"Tartrate-resistant acid phosphatase deficiency in the predisposition to systemic lupus erythematosus","volume":"69","author":"An","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10875-016-0252-y","article-title":"Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey","volume":"36","author":"Briggs","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/ng.748","article-title":"Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature","volume":"43","author":"Briggs","year":"2011","journal-title":"Nat. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-immunol-020711-074953","article-title":"Monogenic autoimmunity","volume":"30","author":"Cheng","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10875-022-01400-8","article-title":"SPENCD presenting with evans phenotype and clinical response to JAK1\/2 Inhibitors-a report of 2 cases","volume":"43","author":"Chougule","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00438-023-02009-1","article-title":"Spondyloenchondrodysplasia in five new patients: identification of three novel ACP5 variants with variable neurological presentations","volume":"298","author":"Elhossini","year":"2023","journal-title":"Mol. Genet. Genomics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1328005","DOI":"10.3389\/fimmu.2023.1328005","article-title":"Case report: refractory evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1\/JAK2 inhibition","volume":"14","author":"Gernez","year":"2024","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ng.749","article-title":"Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity","volume":"43","author":"Lausch","year":"2011","journal-title":"Nat. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1002\/ajmg.a.32518","article-title":"Two further cases of spondyloenchondrodysplasia (SPENCD) with immune dysregulation","author":"Navarro","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"B12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/17453679108994474","article-title":"Spondyloenchondrodysplasia. A rare cause of short-trunk syndrome","volume":"62","author":"Robinson","year":"1991","journal-title":"Acta Orthop. Scand."},{"key":"B14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fendo.2017.00157","article-title":"A case with spondyloenchondrodysplasia treated with growth hormone","volume":"8","author":"Utsumi","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3760\/cma.j.issn.0578-1310.2018.08.011","article-title":"Zhonghua Er Ke Za zhi","volume":"56","author":"Zhong","year":"2018"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1588003\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:26:03Z","timestamp":1753421163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1588003\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":15,"alternative-id":["10.3389\/fphar.2025.1588003"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1588003","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"article-number":"1588003"}}